Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Anavex Life Sciences Corp

Anavex Life Sciences Corp

AVXL · NASDAQ
AVXL · NASDAQ

Next Earnings: 07 May 2025

9.81
USD-0.11-1.11%

Latest News

    @eWhispers
    eWhispers

    Monday morning #earnings https://t.co/lObOE0dOhZ $PDD $HTHT $AVXL $HTOO https://t.co/fxYiqt41Yd

      @cryptomanran
      cryptomanran

      $AVXL Avax Launcher just done a casual 130x!!!! https://t.co/z3IEFzrqsp

      Analysts Recommendations

      Bullish

      Buy

      Strong Buy

      Buy

      Hold

      Sell

      Strong Sell

      Day Range

      9.65USD
      10.03USD

      52 Week Range

      3.25USD
      14.44USD

      Market Cap

      844.69MUSD

      About

      General Information

      Type

      Common Stock

      Exchange

      NASDAQ

      Currency Code

      USD

      Currency Name

      US Dollar

      Country Name

      USA

      Country ISO

      US

      ISIN

      US0327973006

      CUSIP

      032797102

      Sector

      Healthcare

      Industry

      Biotechnology

      Fiscal Year End

      September

      IPO date

      -

      Updated At

      -

      Highlights

      PE Ratio

      -

      PEG Ratio

      -

      Book Value

      1.31

      Dividend Share

      -

      Dividend Yield

      -

      Earnings Share

      -0.54

      Wall Street Target Price

      34.33

      EPS Estimate Current Year

      -0.69

      EPS Estimate Next Year

      2.23

      EPS Estimate Current Quarter

      -0.17

      EPS Estimate Next Quarter

      -0.18

      Most Recent Quarter

      -

      Profitability

      Revenue TTM

      0

      Gross Profit TTM

      0

      EBITDA

      -

      Profit Margin

      0.00%

      Return On Assets TTM

      -24.34%

      Return On Equity TTM

      -37.72%

      Revenue Per Share TTM

      0

      Qtly Revenue Growth YOY

      0.00%

      Diluted Eps TTM

      -0.54

      Qtly Earnings Growth YOY

      0.00%

      Valuation

      Trailing PE

      0.00

      Forward PE

      0

      Price Sales TTM

      0

      Price Book MRQ

      7.6156

      Enterprise Value Revenue

      0

      Enterprise Value EBITDA

      -5

      Peers analysis

      • Alnylam Pharmaceuticals Inc
        ALNYAlnylam Pharmaceuticals Inc

        286.00

        12.65%
      • CSL Limited
        CMXHFCSL Limited

        155.75

        0.48%
      • argenx NV ADR
        ARGXargenx NV ADR

        615.02

        0.16%
      • UCB SA
        UCBJFUCB SA

        190.32

        0.00%
      • Be
        ONCBeiGene, Ltd.

        251.98

        -4.04%
      • Vertex Pharmaceuticals Inc
        VRTXVertex Pharmaceuticals Inc

        502.00

        -1.58%
      • CSL Ltd
        CSLLYCSL Ltd

        80.02

        -0.32%
      • UCB SA ADR
        UCBJYUCB SA ADR

        96.92

        -0.24%
      • BioNTech SE
        BNTXBioNTech SE

        95.98

        -0.21%
      • Regeneron Pharmaceuticals Inc
        REGNRegeneron Pharmaceuticals Inc

        661.00

        -0.21%
      XM

      Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

      Trade with a Trusted, Award-Winning Broker.

      Trading involves risk. The value of investments may go up or down. Trade responsibly.

      FAQs

      What is Anavex Life Sciences Corp stock price today?

      What is Anavex Life Sciences Corp stock ticker?

      Is AVXL stock price going up?

      What is the analyst recommendation for AVXL?

      What is AVXL market cap?

      Does AVXL release financial reports?

      When is AVXL next earnings date?

      What were AVXL Earnings for the last quarter?

      What was AVXL Revenue for the last quarter?

      What was AVXL Net Income for the last quarter?

      Does AVXL pay dividends?

      How many employees does AVXL have?

      What is AVXL EBITDA?

      How to buy AVXL stocks?

      Should I invest in AVXL stock?